Kelly Foley, Ph.D.
Affiliations: | 2013 | Johns Hopkins University, Baltimore, MD |
Area:
Cell Biology, OncologyGoogle:
"Kelly Foley"Parents
Sign in to add mentor| Elizabeth M. Jaffee | grad student | 2013 | Johns Hopkins | |
| (The role of Annexin A2 in invasion and metastasis of pancreatic cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kim VM, Blair AB, Lauer P, et al. (2019) Anti-pancreatic tumor efficacy of a Listeria-based, Annexin A2-targeting immunotherapy in combination with anti-PD-1 antibodies. Journal For Immunotherapy of Cancer. 7: 132 |
| Jurcak NR, Muth S, Fujiwara K, et al. (2019) Abstract 167: Semaphorin3D signaling in the invasion and metastasis of pancreatic ductal adenocarcinoma Cancer Research. 79: 167-167 |
| Jurcak NR, Fujiwara K, Rucki AA, et al. (2018) Abstract 3026: Role of AnnexinA2, Sema3D and PlexinD1 in mediating perineural invasion as a mechanism of metastasis in pancreatic ductal adenocarcinoma Cancer Research. 78: 3026-3026 |
| Murphy AG, Foley K, Rucki AA, et al. (2017) Stromal Annexin A2 expression is predictive of decreased survival in pancreatic cancer. Oncotarget. 8: 106405-106414 |
| Foley K, Muth S, Jaffee E, et al. (2017) Hedgehog signaling stimulates Tenascin C to promote invasion of pancreatic ductal adenocarcinoma cells through Annexin A2. Cell Adhesion & Migration. 0 |
| Blair A, Kim V, Thomas D, et al. (2017) Neoadjuvant and adjuvant vaccine therapy with or without PD1 checkpoint inhibitor therapy in patients with resectable pancreatic cancer: a trial in progress Hpb. 19 |
| Rucki AA, Foley K, Zhang P, et al. (2016) Heterogeneous stromal signaling within the tumor microenvironment controls the metastasis of pancreatic cancer. Cancer Research |
| Kim V, Foley K, Soares K, et al. (2016) Sequential treatment with a listeria-based vaccine and PD-1 blockade antibody improves survival in a murine model of pancreatic ductal adenocarcinoma Hpb. 18: e45-e46 |
| Foley K, Kim V, Jaffee E, et al. (2015) Current progress in immunotherapy for pancreatic cancer. Cancer Letters |
| Soares KC, Rucki AA, Kim V, et al. (2015) TGF-β blockade depletes T regulatory cells from metastatic pancreatic tumors in a vaccine dependent manner. Oncotarget |